Application of the CIBMTR Survival Outcomes Calculator to CD34-Selected Allogeneic HCT for Acute Leukemia and Myelodysplastic Syndrome
Biology of Blood and Marrow Transplantation - Netherlands
doi 10.1016/j.bbmt.2016.12.012
Full Text
Open PDFAbstract
Available in full text
Date
March 1, 2017
Authors
Publisher
Elsevier BV